Comparing Cogentix Medical (CGNT) & Mazor Robotics (MZOR)

Cogentix Medical (NASDAQ: CGNT) and Mazor Robotics (NASDAQ:MZOR) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, valuation, institutional ownership, profitability and analyst recommendations.

Analyst Ratings

This is a summary of current ratings and target prices for Cogentix Medical and Mazor Robotics, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cogentix Medical 0 0 3 0 3.00
Mazor Robotics 2 5 1 0 1.88

Cogentix Medical currently has a consensus price target of $4.58, suggesting a potential upside of 63.69%. Mazor Robotics has a consensus price target of $40.00, suggesting a potential downside of 34.75%. Given Cogentix Medical’s stronger consensus rating and higher probable upside, equities analysts plainly believe Cogentix Medical is more favorable than Mazor Robotics.

Insider and Institutional Ownership

13.3% of Cogentix Medical shares are held by institutional investors. Comparatively, 26.4% of Mazor Robotics shares are held by institutional investors. 62.7% of Cogentix Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.


This table compares Cogentix Medical and Mazor Robotics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Cogentix Medical -36.14% -11.52% -10.04%
Mazor Robotics -28.80% -22.68% -18.29%

Volatility & Risk

Cogentix Medical has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500. Comparatively, Mazor Robotics has a beta of 1.16, indicating that its share price is 16% more volatile than the S&P 500.

Earnings and Valuation

This table compares Cogentix Medical and Mazor Robotics’ gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Cogentix Medical $51.85 million 3.29 -$22.09 million ($0.41) -6.83
Mazor Robotics $36.38 million 43.00 -$18.66 million ($0.71) -86.34

Mazor Robotics has lower revenue, but higher earnings than Cogentix Medical. Mazor Robotics is trading at a lower price-to-earnings ratio than Cogentix Medical, indicating that it is currently the more affordable of the two stocks.


Cogentix Medical beats Mazor Robotics on 8 of the 13 factors compared between the two stocks.

About Cogentix Medical

Cogentix Medical, Inc. is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). The Company also offers Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence that is primarily due to intrinsic sphincter deficiency. The PrimeSight flexible endoscopes are used in conjunction with the sterile, single-use microbial barrier known as the EndoSheath Protective Barrier. The PrimeSight endoscopy line also includes rigid endoscopes and portable peripherals, such as the video system and stroboscopy unit.

About Mazor Robotics

Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications. Its Renaissance System and its predecessor are used in a number of spine surgeries, including fusion, correction of spinal deformities, biopsy collection, tumor excision and cement augmentations. Furthermore the Company developed the Renaissance Brain Module, an application of its Renaissance System that provides control over the insertion of surgical instruments during brain surgery.

Receive News & Ratings for Cogentix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cogentix Medical and related companies with's FREE daily email newsletter.

Leave a Reply